Multipotent adult progenitor cells for hypoxic-ischemic injury in the preterm brain

Preterm infants are at risk for hypoxic-ischemic encephalopathy. No therapy exists to treat this brain injury and subsequent long-term sequelae. We have previously shown in a well-established pre-clinical model of global hypoxia-ischemia (HI) that mesenchymal stem cells are a promising candidate for...

Ausführliche Beschreibung